Weitzen is an assistant professor of Family and Community Medicine at the University of New Mexico School of Medicine. She received her MD from Tel Aviv University in 2012, and completed a residency in family medicine at the UNM in 2015. She joined the DFCM faculty in 2012. Prior to entering medical school, Weitzen completed a an MS in biostatistics from UMass, Amherst and a PhD in epidemiology at Brown University. After earning her PhD, she was a research assistant professor at the Brown School of Medicine in the Department of Obstetrics and Gynecology. She previously worked at the Centers for Disease Control and Prevention at the National Center for Health Statistics.

Weitzen has conducted numerous research studies in the areas of women’s health, end of life, and epidemiologic methods. She has also taught masters level courses in research methods and statistical analyses. Her current research interests include neonatal abstinence syndrome (NAS) and long-term outcomes of children with intrauterine opiate exposure, as well mentoring students, residents and others on how to answer research questions using publicly available health data. She is involved with a pilot randomized control study to evaluate effectiveness of Morphine versus Methadone in treating babies with NAS. She is the PIC of a study to create an NAS risk stratification tool for babies exposed to intrauterine opiates.

Clinically, Dr. Weitzen sees patients at the UNM North Valley Center for Family and Community Medicine, and is an attending physician on the UNMH Newborn and Intermediate care nurseries.